262 related articles for article (PubMed ID: 33121985)
1. A pan-cancer analysis of molecular characteristics and oncogenic role of hexokinase family genes in human tumors.
Jiang M; Liu S; Lin J; Hao W; Wei B; Gao Y; Kong C; Yu M; Zhu Y
Life Sci; 2021 Jan; 264():118669. PubMed ID: 33121985
[TBL] [Abstract][Full Text] [Related]
2. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
3. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
[TBL] [Abstract][Full Text] [Related]
4. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
5. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
Cancer Metab; 2018; 6():7. PubMed ID: 29988332
[TBL] [Abstract][Full Text] [Related]
6. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
Kang M; Lee SM; Kim W; Lee KH; Kim DY
Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
Garcia SN; Guedes RC; Marques MM
Curr Med Chem; 2019; 26(41):7285-7322. PubMed ID: 30543165
[TBL] [Abstract][Full Text] [Related]
8. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Survival Influential Genes in Carcinogenesis.
Sahu D; Chang YL; Lin YC; Lin CC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922264
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
11. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
12. The Roles of HK2 on Tumorigenesis of Cervical Cancer.
Liu C; Wang X; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819871306. PubMed ID: 31530094
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth.
Ros S; Schulze A
Cancer Discov; 2013 Oct; 3(10):1105-7. PubMed ID: 24124231
[TBL] [Abstract][Full Text] [Related]
14. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma.
Zhang MX; Hua YJ; Wang HY; Zhou L; Mai HQ; Guo X; Zhao C; Huang WL; Hong MH; Chen MY
Oncotarget; 2016 Apr; 7(16):21287-97. PubMed ID: 26848773
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
17. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer.
Tutar Y; Özgür A; Tutar E; Tutar L; Pulliero A; Izzotti A
Biomed Pharmacother; 2016 Oct; 83():1182-1190. PubMed ID: 27551766
[TBL] [Abstract][Full Text] [Related]
18. Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo.
Peng Q; Zhou Q; Zhou J; Zhong D; Pan F; Liang H
Cancer Biol Ther; 2008 Jul; 7(7):1128-35. PubMed ID: 18535403
[TBL] [Abstract][Full Text] [Related]
19. Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells.
Katabi MM; Chan HL; Karp SE; Batist G
Hum Gene Ther; 1999 Jan; 10(2):155-64. PubMed ID: 10022541
[TBL] [Abstract][Full Text] [Related]
20. Homophilic anchorage of brain-hexokinase to mitochondria-porins revealed by specific-peptide antibody cross recognition.
Oudard S; Miccoli L; Beurdeley-Thomas A; Dutrillaux B; Poupon MF
Bull Cancer; 2004 Jun; 91(6):E184-200. PubMed ID: 15562563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
